STEMI and heart failure in the elderly: role of adverse remodeling
Authors:
- 13 June 2010
- journal article
- review article
- Published by Springer Nature in Heart Failure Reviews
- Vol. 15 (5) , 513-521
Abstract
The elderly population (age ≥ 65 years) has been increasing worldwide. In North America and Europe, both heart failure (HF) and ST-segment elevation MI (STEMI) are more prevalent in the elderly. Morbidity, hospitalizations and costs associated with HF are higher in the elderly. Despite improved therapies, the bulk of cardiovascular deaths occur in the elderly. Survivors of acute STEMI develop progressive ventricular remodeling that leads to HF. There are several reasons for the increased HF burden in the elderly. First, there is a lack of clinical trial data exclusively in elderly patients for specific therapy of adverse remodeling post-STEMI and HF with low ejection fraction (HF/low-EF) or HF with preserved ejection fraction (HF/PEF). Second, there is the lack of data on the impact of aging on remodeling during healing post-STEMI and HF. Third, HF therapy in the elderly is more challenging because of aging-specific biological changes and associated comorbidities and polypharmacy. More research on aging and post-STEMI remodeling and clinical trials on post-STEMI remodeling and HF in the elderly are needed, especially in the “older-elderly” population segment aged ≥75 years.Keywords
This publication has 72 references indexed in Scilit:
- Reduction in Acute Myocardial Infarction Mortality in the United StatesJAMA, 2009
- Value of Medical Therapy in Patients >80 Years of Age With Heart Failure and Preserved Ejection FractionThe American Journal of Cardiology, 2009
- Aging-Related Defects Are Associated With Adverse Cardiac Remodeling in a Mouse Model of Reperfused Myocardial InfarctionJACC, 2008
- Women and men with unstable angina and/or non-ST-elevation myocardial infarctionWiener klinische Wochenschrift, 2006
- The Polymorphonuclear Leukocyte and the Abdominal Aortic AneurysmCirculation, 2005
- Outcome of patients aged ≥75 years in the SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK (SHOCK) trial: Do elderly patients with acute myocardial infarction complicated by cardiogenic shock respond differently to emergent revascularization?American Heart Journal, 2005
- Impact of age on management and outcome of acute coronary syndrome: Observations from the global registry of acute coronary events (GRACE)American Heart Journal, 2005
- Primary angioplasty with routine stenting compared with thrombolytic therapy in elderly patients with acute myocardial infarctionAmerican Heart Journal, 2003
- Heart failure after myocardial infarction: Prevalence of preserved left ventricular systolic function in the communityAmerican Heart Journal, 2003
- The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs.Circulation, 1977